P.025 Is a complete viral load suppression required to reduce the risk of cytomegalovirus recurrence in kidney transplant recipients using the preemptive strategy?
Mr. Pedro H. Oliveira Sr., Brazil
P.026 Longitudinal SARS-CoV-2 antibody and T-cell immune responses in vaccinated kidney transplant recipients and patients on dialysis
Mr. Pedro H. Oliveira Sr., Brazil
P.056 High-Dose Intravenous Immunoglobulin for BK Virus DNaemia Protects Against BK Nephropathy But Not Acute Rejection
Dr. Hersharan Kaur Sran, Singapore
P.061 Gut microbiota composition and metabolites reflects disease severity and short-term allograft function in renal transplant recipients with COVID-19
Prof. Zijie Wang, People's Republic of China
P.120 Dynamic trends in deceased donor kidney utilization: Unraveling discard rates and KDPI shifts across pre-COVID, COVID, and post-COVID eras
Jeffrey P Orlowski, United States
P.122 The outcomes of renal transplantation during the covid-19 pandemic. Is it worth doing?
Dr. Abdul Khalique, Pakistan
P.123 Covid -19 infection in simultaneous pancreatic kidney transplant recipients - First case series from Asia
Dr. Belmin BJ Winston Gysley, India
P.124 COVID-19 Positive Kidney Transplant Recipients behave differently compared to non-transplant patients’ ICU: single center experience.
Dr. Osama Gheith, Egypt
P.125 Add-on Extracorporeal Membrane Oxygenation in critically ill COVID-19 positive patients: risk factors and predictors of survival.
Dr. Osama Gheith, Egypt
P.127 Covid-19 infection in a large cohort of kidney transplant recipients from a single center
Dr. Aygul Celtik, Turkey
P.131 A nationwide report of long term covid-19 sequalae in kidney transplant recipients: Largest report from India
Dr. Sudeep Desai, India
P.132 Immune Response after 2 doses of Vaccine against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS Cov-2) Infection among Patients of Renal Transplantation
Dr. MD Masud Iqbal, Bangladesh
P.133 Identification of risk of malaria and selective post-transplant testing of deceased organ donors in the UK
Ines Ushiro-Lumb, United Kingdom
P.137 Which immunodeficiency status has greater risks of poor pneumocystic pneumonia outcomes than other immunocompromised populations?
Dr. Poramed Winichakoon, Canada
P.139 Covid-19 infection outcomes of the kidney transplant recipients in Mongolia
Dr. Khishgee Tseren, Mongolia
P.142 Frequency of urinary tract infection by multi-drug resistance organisms and its effect on graft function in renal transplant recipients
Dr. Muhammad Tassaduq Khan, Pakistan
P.143 Diabetes mellitus as a risk factor for urinary tract infections in kidney transplant recipients
Prof. Nada Kanaan, Belgium
P.144 Is not treating ≤3000 IU /ml of Cytomegalovirus viremia safe in living donor R+D+ renal transplant recipients?
Dr. Sunil Kumar Dodani, Pakistan
P.150 Viral infections in pediatric kidney transplant recipients: Impact on graft function, risk factors, and patient outcomes
Prof. Esra Baskin, Turkey
P.151 Multinational, retrospective study assessing treatment patterns, outcomes, and healthcare resource utilization in solid organ transplant recipients with cytomegalovirus infection and intolerance to anti-cytomegalovirus treatments
Mrs. Kimberly H Davis, United States
P.152 Respiratory multiplex PCR could predict morbidity and mortality in solid organ transplant patients
Dr. Dorina Rama Esendagli, Turkey
P.117 Profile of Tuberculosis in Kidney Transplant Recipients: A Single Centre Experience from Central India